Device is a combination product.Device evaluated by mfr.: it is indicated that the device will not be returned for evaluation.A review of the batch history, historical trending, and similar complaint trending review for the product family will be conducted.If there is any further relevant information from that review, a supplemental medwatch will be filed.(b)(4).
|
Same case as 2134265-2015-08626, 2134265-2015-08627 and 2134265-2015-08628.(b)(6) clinical study.It was reported that patient death occurred.In (b)(6) 2012, the patient presented due to unstable angina and was referred for cardiac catheterization which revealed two target lesions.Target lesion # 1 was a de novo lesion located in the 1st obtuse marginal (om) artery extending to the 2nd om with 99% stenosis and was 15mm long with a reference vessel diameter of 2.75mm.Target lesion # 1 was treated with pre-dilatation and placement of 2.75 x 20mm, 2.25 x 16mm and 2.50 x 32mm promus element plus stents with 0% residual stenosis.Target lesion # 2 was a de novo lesion located in the distal left anterior descending artery (lad) extending to the 1st diagonal artery with 99% stenosis and was 15mm long with a reference vessel diameter of 2.75mm.Target lesion # 2 was treated with pre-dilatation and placement of a 2.50 x 32mm pe plus stent with 0% residual stenosis.One day post procedure, the patient was discharged on aspirin and prasugrel.In (b)(6) 2015, the patient was brought to the emergency medical service (ems) for altered mental status and hypotension.Subsequently, the patient was admitted for septic shock likely from suspected c.Dificile, severe hyponatremia, acute kidney injury (aki), severe hypotension and candidal urinary tract infection (uti).The patient was placed on levophed and ventilation support due to sepsis and acute respiratory failure.During the course of hospitalization, the patient was also diagnosed with non st segment elevated myocardial infarction (nstemi) and suffered from episodes of tachycardia/ supraventricular tachycardia (svt).Events were medically treated but due to the development of gastrointestinal (gi) bleeding, levonox was discontinued.The patient was also referred to wound care for management of (b)(6) and sacral ulcerations.The patient became more septic with high fevers, elevated white blood count (wbc) and lactic acidosis.After multiple discussions with the family on the patient's poor prognosis, code status 5 was initiated with withdrawal of all medical measures.In (b)(6) 2015, the patient died.Cause of death was unknown whereas preliminary cause of death was cardiac arrhythmia.
|